R C Landis
Overview
Explore the profile of R C Landis including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
31
Citations
511
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Thannesberger J, Rascovan N, Eisenmann A, Klymiuk I, Zittra C, Fuehrer H, et al.
Parasit Vectors
. 2021 Jun;
14(1):343.
PMID: 34187544
Background: The Zika virus (ZIKV) epidemic of 2015/2016 spread throughout numerous countries. It emerged in mainland Latin America and spread to neighboring islands, including the Caribbean island of Barbados. Recent...
2.
Landis R, Durandy Y
Anaesth Intensive Care
. 2017 Mar;
45(2):275.
PMID: 28267952
No abstract available.
3.
Marshall K, Swaby K, Hamilton K, Howell S, Landis R, Hambleton I, et al.
Ann Trop Paediatr
. 2011 Jan;
31(1):27-36.
PMID: 21262107
Background: The causes of oedematous vs non-oedematous childhood malnutrition (OM vs NOM) remain elusive. It is possible that inherited differences in handling oxidant stressors are a contributing factor. Aims: To...
4.
Landis R, Evans B, Chaturvedi N, Haskard D
Diabetologia
. 2010 Apr;
53(7):1537-8.
PMID: 20419448
No abstract available.
5.
Evans B, Haskard D, Finch J, Hambleton I, Landis R, Taylor K
J Thorac Cardiovasc Surg
. 2008 May;
135(5):999-1006.
PMID: 18455576
Objective: Extravascular trafficking of leukocytes into organs is thought to play a major role in the pathophysiologic mechanisms of the inflammatory response to cardiopulmonary bypass, yet leukocyte extravasation is difficult...
6.
Day J, Landis R, Taylor K
Semin Cardiothorac Vasc Anesth
. 2006 Sep;
10(2):132-42.
PMID: 16959740
Cardiopulmonary bypass, although remaining an indispensable asset in cardiac surgery, especially in more complex and repeat operations, is associated with significant thrombin generation in the bypass circuit, leading to the...
7.
Day J, Punjabi P, Randi A, Haskard D, Landis R, Taylor K
Circulation
. 2004 Jul;
110(17):2597-600.
PMID: 15262827
Background: Protease-activated receptor-1 (PAR1) is the principal thrombin receptor in the vasculature, and antagonists against this receptor are in preclinical trials. Aprotinin, already approved for clinical use to reduce transfusion...
8.
Day J, Malik I, Weerasinghe A, Poullis M, Nadra I, Haskard D, et al.
Heart
. 2004 Jun;
90(7):794-9.
PMID: 15201252
Objective: To study the effect of unfractionated heparin (UFH) versus low molecular weight heparin (LMWH) in combination with glycoprotein (Gp) IIb/IIIa blockers on platelet activation and aggregation. Methods: Washed platelets...
9.
Day J, Landis R, Taylor K
J Cardiothorac Vasc Anesth
. 2004 Feb;
18(1):93-100.
PMID: 14973810
No abstract available.
10.
Philippidis P, Mason J, Evans B, Nadra I, Taylor K, Haskard D, et al.
Circ Res
. 2003 Dec;
94(1):119-26.
PMID: 14656926
The recently described hemoglobin scavenger receptor CD163 mediates the endocytosis of hemoglobin:haptoglobin (Hb:Hp) complexes and thereby counters Hb-induced oxidative tissue damage after hemolysis. Although CD163 has been indirectly associated with...